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Using polymerase chain reaction, we have isolated and se-
quenced a 3-kb cDNA for lysyl hydroxylase (LH) from 
human skin fibroblasts from an normal donor. Apart from 
two polymorphic sites, no differences were observed be-
tween the 2184 nt coding regions ofLH cDNA from fibro-
blasts and placenta. However, four differences were observed 
in the 3' non-coding regions of the two cDNAs; three were 
single base changes and the fourth a deletion of a single base. 
The absence of the single nucleotide in the LH cDNA from 
L YSYI hydroxylase (LH) is an important enzyme in colla-gen biosynthesis that catalyzes the formation of hy-droxylysine, which is essential for the intermolecular crosslinking of collagen [1]. The requirement for LH is demonstrated in patients with Ehlers-Danlos syn-
drome type VI (EDS VI), a connective tissue disorder char-
acterized by decreased levels of LH activity [2,3]. The severity 
of symptoms in these patients varies greatly and does not neces-
sarily correlate with the same degree of impaired hydroxylation [4]. 
Although the biochemical properties of LH from various tissues 
synthesizing different collagen types are remarkably similar [5], 
the variability in the types of collagens that are hydroxylated 
and the localization of underhydroxylated collagens in specific 
tissues suggests that a family of LH isozymes may exist, each 
with its own specificity in different tissues for different collagen 
types [6,7]. 
We have recently reported the sequence of a partial cDNA 
(2.2 Kb) for LH from dermal fibroblasts from a normal donor [8], 
which has been completed in the present study. A comparison of our 
fibroblast LH cDNA sequence with the recently published sequence 
of human placental LH cDNA [9] shows several single base 
changes, two of which appear to be polymorph isms, and one single 
base deletion that results in the loss of an Hpall site in the 3' non-
coding region. In addition, we have examined expression of the LH 
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fibroblasts resulted in the loss of an HpaII site that is present 
in the placental LH cDNA; this was confirmed in Hpall 
digests of fibroblast and placental LH cDNAs from the same 
donor. Northern blots showed that the LH gene was strong!y 
expressed in fibroblasts and placenta and, to a lesser extent, ill 
aorta, lung, vein, cartilage, and artery. Key words: collagen 
biosynthesis / hydroxylysine / polymorphism / Ehlers-Danlos syn-
drome type VI. ] Invest Dermatol1 02:382 - 384, 1994 
gene in different tissues by Northern blot hybridization of total 
RNA to our 2.2 Kb cDNA for LH. 
MATERIALS AND METHODS 
Cell Strains and Tissues The fibroblast cell strains were from a nor-
mal 14-month-old boy (GM05659), a normal newborn boy (AG01519Al 
(both strains obtained from the Institute for Medical Research. Camden, 
NJ), and an explant from a skin biopsy from a normal female donor 
(AMS1106). Placental tissue was obtained from the same donor (AMS), 
Tissue samples of aorta, diaphragm, dura, esophagus, gall bladder, lung, 
vein, spleen, cartilage, artery, and intestine were obtained from another 
donor (EH). 
RNA Isolation 
Dermal Fibroblasts: Total RNA was isolated from approximately 6>< 10
6 
fibroblast cells, by the acid-guanidinium thiocyanate-phenol-chloroford 
extraction method as previously described [8J . Poly (A) RNA was prepare 
using oligo (dT)-cellulose columns [8]. 
Human Tissue: Each tissue sample was pulverized with a pestle and rnor-
tar, and cooled with liquid nitrogen; total RNAs were isolated as desCr1b~d 
for fibroblast cells using 5.4 ml of guanidinium thiocyanate per 1 g cIS" 
sue. 
Norti,en, Blot AI/alysis: Total RNAs (9 ,ug) from fibroblasts, placenta. and 
other human tissues with the exception of cartilage, artery, and intestine 
(6,ug RNA) were separated electrophoretically and blotted [8J. The blotS 
were hybridized with the random-primed 32P-labeled 2.2-Kb eDNA probe 
for LH as previously described [8J. 
Isolation, Atnplineation, and Sequencing of a eDNA for LH We 
have recently described the amplification and sequencing of a partial cDNA 
for LH from dermal fibroblasts (GM05659) encompassing a 2.2-Kb se-
quence from nt 760 to nt 2939 preceding the poly (A) tail. The approJ{l-
mately 800 bases remaining at the 5' end of the LH cDNA were amplified ba 
a 5' RACE technique [10J (Gibco-BRL). First-strand eDNA was syntheSIze 
from poly (A)+ RNA isolated from dermal fibroblasts using, as primer, che 
sequence complementary to nt 898-917 of LH cDNA and reverse trall, 
scriptase. The 5' end of the cDNA was dC-tailed using dCTP and terrnlna 
deoxynucleotidyl transferase. This was followed by PCR amplificatiOll 
using. as 3' amplification primer, the nested sequence complementary to llC 
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Figure 1. Sequence differences between LH cDNAs from human skin 
fibroblasts and placenta. The lilJe represents the sequence ofLH cDNA from 
human skin fibrob lasts (not shown to scale). The vertical arrows at nts 25 and 
2205 delineate the start and stop of the coding region (thicker lille); the nts in 
the placental LH cDNA that differ from fibroblast cDNA are shown above 
the lille. The only predicted aa change is a Thr (placenta) for Ala •• (fibro-
blast). The asterisk represents the loss of em! in fibroblast LH cDNA. The 
numbering is based on the sequence of fibroblast LH cDNA, GenBank 
accession number, M98252. 
808 -827 and as 5' amplification primer, an anchor primer containing a poly 
(dG) region. The amplified sequence was gel-purifie.d and cycle-sequenced 
(Glbco-BRL) in both directions. The sequence differences in this cDNA 
from the LH cDNA sequence of human placenta [9] were confirmed by 
sequence analysis of these regions in a fibroblast LH cDNA isolated from 
another donor (AGOI519A). 
Restriction Digests with Hpall First-strand cDNA was synthesized 
from poly (A)+ RNA isolated from fibroblasts and placenta from the same 
donor (AMS). Amplification of the 1326-bp region covering the Hpall 
dtfference at nt 2381 was carried out using as 5' primer the sequence nt 
1497 -ISIS, and as 3' primer the sequence complementary to nt 2805-
2823. Polymerase chain reaction amplification was performed under previ-
ously described conditions [8]. The gel-purified (Glassmax; Gibco-BRL) 
~326-bp fragments from fibroblasts and placenta were digested with Hpall. 
he digests were electrophoresed on a 3% NuSieve-l % agarose gel and 
Visualized by ethidium bromide- UV fluorescence. 
RESULTS AND DISCUSSION 
The 2939-bp cDNA for LH from human skin fibroblasts has an 
open reading frame of2184 nts coding for a 727 -amino acid poly-
feptide of similar size to that previously reported for the LH cDNA 
rom human placenta [9]. There are some differences in the fibro-~~ast L~ cDNA s~quenc~ from the placental sequence as shown in 
( 
19 1; 111 the codlI1g regIOn, however, the changes of G319 for A 
Ala99 ~ Thr) and C 1230 for T (conserved Asn402) appear to be at 
polymorphic sites. The change of G319 for A has been reported by ~autala et al [11] in some of their placental clones, and also we have 
o served in our recent sequence analysis of two mutant LH alleles in 
fibroblasts from an EDS VI patient (Ha et ai, manuscript subm.itted) 
:hat o~e. allele had an A at nt 319, again indicative of polymorphism. h additIOn, the presence of a T at nt 1230 in the other allele suggests 
t at this site is also polymorphic. 
In the 3' non-coding region the fibroblast sequence differs from ~~e placental sequence by three single base changes as shown in 
Ig 1. In addition, the fibroblast sequence lacks a C betweennt 2380 
3hd nt 2381 that is present in the placental sequence and results in tie loss of an Hpall site. We confirmed the loss of this Hpall site by 
e hctrophoresis ofHpaII restriction digests of a 1326-bp polymerase 
C am reaction-amplified region of fibroblast and placental cDNA 
}Solated from the same donor (Fig 2A) . This showed that the 912-bp 
(~agrnent from the fibroblast digest replaced the two fragments 
. 70 bp and 442 bp) from the placental digest (Fig 2B), thus verify-
Ing the loss of this Hpall site in fibroblast cDNA. As the cDNAs 
clere obtained from skin fibroblasts and placenta from the same 
onor, this would indicate that this is not a simple polymorphic 
~hflallt. but a true difference between the LH cDNAs isolated from 
ese tissues. 
We have previously observed [8] that the 2.2-Kb LH cDNA 
bfobe hybridizes with two mRNAs of 2.4 and 3.4 Kb on Northern 
tOts of total RNA isolated from fibroblasts. This probe hybridized 
s tongly to Northern blots of total RNA (Fig 3) isolated from pla-
Centa (lane 7) and skin fibroblasts (la/Ie 10). The LH gene was also 
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Figure 2. Electrophoresis of Hpall digests of polymerase chain reaction-
amplified sequences from fibroblast and placental cDNAs showing loss of an 
Hpall site in fibroblast cDNA. A) A 1326-bp region in the LH cDNAs from 
fibroblast and placenta was amplified by polymerase chain reaction and 
digested with HpaII: Ethidium bromide staining of the digests electrophor-
esed on a 3% NuSleve -1 % agarose gel (major fragments identified by 
arrows) showed that the largest-sized fragment from the fibroblast digest 
(latle 3) was approximately twice the size of the largest fragments from the 
placental digest (latle 2). LatJe 1 represents electrophoresis of2 Ji-g of a l-Kb 
DNA ladder with the sizes marked as shown. B) Location of the Hpall 
restriction sites (H) in the amplified sequences of fibroblast and placental LH 
cDNAs between nt 1497 and 2823 (vertical arrows). The site at nt 2381 
present m placental cDNA but absent in fibroblast cDNA is marked with an 
asterisk. Fragment sizes in base pairs are marked below the lines. The larger 
912-bp fragment from the fibroblast digest observed in the gel electrophore-
SIS (A) confirms the loss of the Hpall site at nt 2381. The coding and 
1I0ncodmg sequences are represented by thicker and t!tirltler lilies, respectively. 
expressed, although to a lesser extent, in other human tissues in-
cluding aorta, lung, vein, cartilage, artery, and to a lesser extent 
spleen and gall bladder. Although the LH mRNAs were variably 
expressed in these tissues, they appeared to be of identical sizes. 
Little or no LH mRNA was detected in diaphragm, dura, esopha-
gus, or intestine. Other studies have shown considerable expression 
of the mRNAs for LH in endothelial cells and, to a lesser extent, in 
keratinocytes (data not shown). 
In summary, sequencing of a cDNA for LH isolated from dermal 
fibroblasts has shown some differences from the placental cDNA. 
Although certain of these changes may represent simple polymor-
phic variants, a true difference in the 3' noncoding region between 
fibroblast and placental LH cDNA has been identified by HpaJI 
restriction digests. Whether these differences are the result of 
alternative splicing of RNA from the same gene, are the products 
of different genes, or occur via another mechanism remains to 
be determined; however, slIch studies should yield some insight 
into variables such as the phenotypic differences of LH-deficient 
EDS VI individuals and the tissue specificity of lysyl hydroxyla-
tion . 
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Figure 3. Northern blot showing expression of LH in human tissues. 
A) Total RNA was isolated from fibroblasts and several human tissues as 
described in Materials and Methods. Nine micrograms total RNA (lanes 1-10) 
and 6 Ilg total RNA (lanes 11 -13) were electrophoresed and transferred to 
GeneScreen Plus membrane, and the blot was hybridized with the 2.2 Kb 
cDNA probe for LH (which detects both 2.4 and 3.4 Kb mRNAs), as de-
scribed. B) The uniformity of loading of RNA samples was assessed by 
comparison of the rRNAs (18S and 28S) detected by ethidium bromide 
staining and UV fluorescence. 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
This work was supported itl part by Research Grant AG10215 frolll the National 
InstiUlle on Aging (HNY); by t!.eJohn A. Hartford FOIHldation (WLG); atld by a 
Loo Stead Research Scholarship (VH). HNY is a Senior Fellow of the Get/ter for the 
Study of Aging and HUlllall Developlllet/t at Duke Ulliversity Medical GeIIter. The 
software package of the GGG at the Ulliversity of WiscoflSill lIIas IIsed for sequence 
analysis. 
We 1IJ0uid also like to thank Margaret Poole and Vicki Miclwelfor ti,eir excellen t 
help ill typing this matHlscript. 
REFERENCES 
1. Pinnell SR, Murad S: Disorders of collagen. In: Stanbury JB, Wyngaarden JB, 
Frederickson DS, Goldstein JL, Brown ML (cds.). The Metabolic Basis ofIllheriled 
Disease. McGraw-Hili, New York, 1983, pp 1425-1449 
2. Pinnell SR, Krane SM, Kellzora JE, Glimcher MJ: A heritable disorder of connec-
tive tissue: hydroxylysine-deficicnt collagen disease. N ElIgl] Med 286:1013-
1020, 1972 
3. Krane SM, Pinnell SR, Erbe RW: Lysyl-protocollagen hydroxylase deficiency in 
fibroblasts from siblings with hydroxylysine-deficient collagen. Proc Noll Acad 
Sci USA 69:2899-2903, 1972 
4. Wenstrup RJ, Murad S, Pinnell SR: Ehlers-Danlos syndrome type VI: Clinical 
manifestations of collagen lysyl hydroxylase deficiency.] Pedialr 115:405 _409, 
1989 
5. Puistola U: Catalytic properties of lysy l hydroxylase from cells synthesizing ge-
netically different collagen types. Bio,!.em] 201:215-219,1982 
6. Ihme A, Krieg T, Nerlich A, Feldman V, RauterbergJ, Glanville RW, Edcl G, 
MoIler PK: Ehlers-Danlos syndrome type VI: collagen rype specificity of de-
fective lysyl hydroxylation in various tissues.] Illvest Dermatol 83:161-165, 
1984 
7. Yeowell HN, Pinnell SR: The Ehlers-Danlos syndromes. Semill Dermatol 
12:229 -240,1993 
8. Yeowell HN, Ha V, Walker LC, Murad S, Pinnell SR: Characterization of a 
partial eDNA for lysyl hydroxylase from human skin fibroblasts; Iysyl hydroX-
ylase mRNAs arc regulated differently by minoxidil derivatives and hydrala-
zine.] Illvest DermatoI99:864-869, 1992 
9. Hautala T, Byers MG, Eddy RL, Shows TB, Kivirikko Kl, Myllyla R: Cloning of 
human lysyl hydroxylase: complete eDNA-derived amino acid sequence a~d 
assignment of the gene (PLOD) to chromosome 1 p36.3 -+ p36.2. GellolllICS 
13:62-69, 1992 
10. Frohman MA, Dush MK, Martin GA: Rapid production of full-length eDNA' 
from rare transcripts: amplification using a single gene-specific oligonucleotide 
primer. Pro, Natl Acad Sci USA 85:8998 - 9002, 1988 
11. Hautala T , Heikkinen J, Kivirikko K, Myllyla R: A large duplication in the gene 
for Iysyl hydroxylase accounts for the Type VI variant of Ehlers-Danlos syn-
drome in two siblings. Gellomics 15:399-404, 1993 
